Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target
This study was published in the Journal Cell on Oct 12, 2024, co-authored by several Greenstone Biosciences employees in collaboration […]
Tackling the challenges of new approach methods for predicting drug effects from model systems
Excited to share our latest commentary in Nature Reviews Drug Discovery! We delve into the challenges and advancements in using
Greenstone Biosciences is a proud sponsor of the 2024 Stanford Drug Discovery Symposium that was held at Stanford between April 29-30.
Greenstone Biosciences is a proud sponsor of the 2024 Stanford Drug Discovery Symposium that was held at Stanford between April
Statins improve endothelial function via suppression of epigenetic-driven EndMT.
Liu C, Shen M, Tan WLW, Chen IY, Liu Y, Yu X, Yang H, Zhang A, Liu Y, Zhao MT,
Greenstone Biosciences is proud to be a sponsor of the 2023 Stanford Drug Discovery Symposium
Greenstone Biosciences is a proud sponsor of the 2023 Stanford Drug Discovery Symposium that was held at Stanford between April
Greenstone Biosciences makes human induced pluripotent stem cell lines available to academic institutions for free
Greenstone Biosciences announces that it will be making available its collection of healthy human iPS cell lines and lines with pathogenic variants
Greenstone Bio welcomes Nobel Laureate Brian Kobilka to their Scientific Advisory Board
Greenstone Biosciences co-founder Joseph C. Wu and BOD Lip-Bu Tan are honored and excited to welcome Brian Kobilka, Professor of Molecular & Cellular Physiology at
Stanford’s Joseph Wu to be president of the American Heart Association
Beginning July 2023, Wu will lead the nation’s largest nonprofit organization dedicated to advancing cardiovascular health. Read Original Article
Joseph Wu, MD, PhD, elected to the National Academy of Medicine
Due to the pandemic the inauguration ceremony was delayed and took place in Washington, DC, on October 15, 2022. Dr.